Donor pretreatment with leflunomide has an adverse effect on rat cardiac allograft survival

By DeRoover A.   Williams A.   Hubscher S.   Candinas D.   Antoniou E.   Howie A.   Drayson M.   McMaster P.   D'Silva M.  

Transplant Immunology, Vol. 5, Iss. 2, 1997-06 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Monoclonal antibody to the HLA class I 3 domain inhibits T cell activation and prolongs cardiac allograft survival in HLA- transgenic mice

By Woo J.   Corjeno M.-C.   Gao L.   Taurog J.D.   Hammer R.E.   Buelow R.  

Transplant Immunology, Vol. 5, Iss. 2, 1997-06 ,pp. : 112-121

Elsevier

Access to resources Recommend Favorite

Intrathymic inoculation of donor B cells prolongs cardiac allograft survival by non-deletional mechanisms

By Niimi M.   Morris P.J.   Wood K.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 94-94

Elsevier

Access to resources Recommend Favorite

Donor Pretreatment With Methylprednisolone Synergistically Prolongs Survival of Cardiac Allografts in Sensitized Rat Recipients Conditioned With Rapamycin

By Schmidbauer G.   Homeyer A.   Bohle R.M.   Grimm H.   Binder J.   Kupiec-Weglinski J.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 607-608

Elsevier

Access to resources Recommend Favorite

Prolonged skin allograft survival by IL-10 gene-introduced CD4 T cell administration

By Miyamoto Takeshi  

International Immunology, Vol. 17, Iss. 6, 2005-06 ,pp. : 759-768

Oxford University Press

Access to resources Recommend Favorite